Skip to main content

Table 2 Means ± SD (min–max) of the age, body composition score, serum protein, albumin and globulin concentrations, and peak xylose concentration, the numbers of horses with each abnormal finding and the length of treatment in long-term (3 years) survivors and non-surviving horses

From: Diagnostic evaluation and short-term outcome as indicators of long-term prognosis in horses with findings suggestive of inflammatory bowel disease treated with corticosteroids and anthelmintics

 

Survivors (n = 13)

Non-survivors (n = 7)

P

Age (years)

9.7 ± 4.5 (3–17)

10.0 ± 5.3 (4–20)

0.893

Body score

3.9 ± 1.4 (2–7)1

3.6 ± 0.5 (3–4)

0.598

S-protein (g/L)

61.6 ± 8.3 (44.2–77.2)

53.4 ± 11.9 (30.6–69.6)

0.086

S-albumin (g/L)

33.1 ± 5.5 (20.3–40.8)

31.4 ± 8.7 (14.7–39.4)

0.843

S-globulin (g/L)

28.5 ± 7.5 (21.3–46.4)

22.0 ± 6.8 (15.5–30.9)

0.073

Peak xylose (mmol/L)

1.36 ± 0.44 (0.85–2.27)

0.94 ± 0.36 (0.27–1.37)

0.048

Length of treatment (d)

51.1 ± 13.2 (22–69)

71.1 ± 32.8 (43–120)2

0.065

  1. 1Data missing from two surviving horses.
  2. 2One horse is not included in this calculation as it was euthanized on humane grounds after 26 days of treatment.